FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:72 July 6, 2000 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Kell, one of the major red-cell groups in humans, comprises 22 antigens. These antigens are encoded by alleles on chromosome 7, including sets of antithetical antigens such as Kell (K) and Cellano (k), which differ by a single amino acid.¹ Anti-Kell antibodies have been shown to suppress the growth of erythroid progenitor cells in a semisolid culture system.² This finding has been linked to the reticulocytopenia that is usual in hemolytic disease of the newborn (erythroblastosis neonatorum) induced by anti-Kell antibodies.³ We recently observed substantial thrombocytopenia in three fetuses with erythroblastosis fetalis due to anti-Kell antibodies (platelet . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Yu, L.-C., Twu, Y.-C., Chang, C.-Y., Lin, M. (2001). Molecular Basis of the Kell-null Phenotype. A MUTATION AT THE SPLICE SITE OF HUMAN KEL GENE ABOLISHES THE EXPRESSION OF KELL BLOOD GROUP ANTIGENS. J. Biol. Chem. 276: 10247-10252 [Abstract] [Full Text]